426 related articles for article (PubMed ID: 24117661)
1. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ
Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692
[TBL] [Abstract][Full Text] [Related]
3. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Cid S; Eiro N; González LO; Beridze N; Vazquez J; Vizoso FJ
Clin Breast Cancer; 2016 Aug; 16(4):e83-91. PubMed ID: 27266802
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
González LO; Pidal I; Junquera S; Corte MD; Vázquez J; Rodríguez JC; Lamelas ML; Merino AM; García-Muñiz JL; Vizoso FJ
Br J Cancer; 2007 Oct; 97(7):957-63. PubMed ID: 17848954
[TBL] [Abstract][Full Text] [Related]
8. Study of matrix metalloproteinases and their inhibitors in breast cancer.
Vizoso FJ; González LO; Corte MD; Rodríguez JC; Vázquez J; Lamelas ML; Junquera S; Merino AM; García-Muñiz JL
Br J Cancer; 2007 Mar; 96(6):903-11. PubMed ID: 17342087
[TBL] [Abstract][Full Text] [Related]
9. Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.
Fernández-Guinea O; Álvarez-Cofiño A; Eiró N; González LO; del Casar JM; Fernandez-Garcia B; Lamelas ML; Andicoechea A; Vizoso FJ
Int J Clin Oncol; 2013 Aug; 18(4):629-40. PubMed ID: 22688161
[TBL] [Abstract][Full Text] [Related]
10. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.
Têtu B; Brisson J; Wang CS; Lapointe H; Beaudry G; Blanchette C; Trudel D
Breast Cancer Res; 2006; 8(3):R28. PubMed ID: 16776850
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblast-like cells adjacent to invasive ductal carcinoma of the breast.
Min KW; Kim DH; Do SI; Pyo JS; Kim K; Chae SW; Sohn JH; Oh YH; Kim HJ; Choi SH; Choi YJ; Park CH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S433-42. PubMed ID: 23115007
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas.
González LO; González-Reyes S; Marín L; González L; González JM; Lamelas ML; Merino AM; Rodríguez E; Pidal I; del Casar JM; Andicoechea A; Vizoso F
Histopathology; 2010 Dec; 57(6):862-76. PubMed ID: 21166700
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
17. Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.
Eiró N; González LO; Atienza S; González-Quintana JM; Beridze N; Fernandez-Garcia B; Pérez-Fernández R; García-Caballero T; Schneider J; Vizoso FJ
Eur J Cancer; 2013 Mar; 49(5):1009-17. PubMed ID: 23063352
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
20. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]